In our study, we aim to analyze anxiety and depression symptoms and QoL outcomes in MI sufferers followed in a CRP without dedicated MH resources and explore characteristics associated with persistent MH alterations after Phase 2 CRP, which may identify patients who could benefit most from MH interventions. Here, CRP is linked to depressive disorder.